MZMarta Zafra

Marta Zafra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Zafra has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prospective study of predictors for anxiety, depression, and somatization in a sample of 1807 cancer patients

    by Veronica Velasco-Durantez, Patricia Cruz-Castellanos, Raquel Hernandez, Adan Rodriguez-Gonzalez, Ana Fernandez Montes, Alejandro Gallego, Aranzazu Manzano-Fernandez, Elena Sorribes, Marta Zafra, Alberto Carmona-Bayonas, et al.

    In cancer patients, psychological distress, which encompasses anxiety, depression, and somatization, arises from the complex interplay of emotional and behavioral reactions to the diagnosis and treatment, significantly influencing their functionality and quality of life. The aim was to investigate factors associated with psychological distress in cancer patients. This prospective and multicenter study, conducted by the Spanish Society of Medical Oncology (SEOM), included two cohorts of patients with cancer (localized resected or advanced unresectable). They completed surveys assessing psychological distress (BSI-18) before and after cancer treatment and coping (MINI-MAC) and spirituality (FACIT-sp) prior to therapy. A multivariable logistic regression analysis and a Structural Equation Modeling (SEM) were conducted. Between 2019 and 2022, 1807 patients were evaluated, mostly women (54%), average age 64 years. The most frequent cancers were colorectal (30%), breast (25%) and lung (18%). Men had lower levels of anxiety and depression (OR 0.66, 95% CI 0.52–0.84; OR 0.72, 95% CI 0.56–0.93). Colorectal cancer patients experienced less anxiety (OR 0.63, 95% CI 0.43–0.92), depression (OR 0.55, 95% CI 0.37–0.81), and somatization (OR 0.59, 95% CI 0.42–0.83). Patients with localized cancer and spiritual beliefs had reduced psychological distress, whereas those with anxious preoccupation had higher level. SEM revealed a relationship between psychological distress and coping strategies, emphasizing how baseline anxious preoccupation exacerbates post-treatment distress. This study suggests that age, sex, extension and location of cancer, coping and spirituality influence psychological distress in cancer patients.


  • Open Access

    Assessment of psychological distress, coping, and spirituality in patients with resected, non-metastatic vs unresectable advanced cancer. Data from the NEOcoping and NEOetic_SEOM studies

    by Veronica Velasco, Patricia Cruz-Castellanos, Raquel Hernandez, Adan Rodriguez-Gonzalez, Ana Fernandez Montes, Alejandro Gallego, Aranzazu Manzano-Fernandez, Elena Sorribes, Marta Zafra, Alberto Carmona-Bayonas, et al.

    Background Cancer negatively affects patients’ physical and mental health. This work sought to analyze the sociodemographic and clinical variables that modulate psychological distress in individuals with resected vs unresectable cancer before and after receiving systemic antineoplastic treatment, and to evaluate how different coping strategies and spiritual well-being influence psychological distress in these subjects. Methods Observational, prospective, consecutive study performed in 15 hospitals in Spain. The study consists of two cohorts: patients with resected locally and locally advanced cancer receiving adjuvant chemotherapy (NEOcoping study, 2016 and 2018) and those with unresectable locally advanced and advanced cancer, eligible for systemic treatment (NEOetic study, 2020 and 2021). Participants completed the following scales: BSI-18 (psychological distress) at baseline and after antineoplastic treatment; MINI-MAC (coping), and FACIT-sp (spirituality), before initiating systemic treatment. Results Fourteen hundred and fifty patients were recruited; 941 had resected cancer and 509 had advanced cancer. The advanced cancer sample included more males, older, less educated, and more unemployed individuals. Before starting systemic treatment, the advanced, unresectable disease group suffered more psychological distress than those with resected cancer (66.9 vs. 63.7, p=0.001) and used more coping strategies, especially positive attitude (79.1 vs. 75.6, p=0.001) and cognitive avoidance (64.3 vs. 53.6, p=0.001). Participants with resected cancer displayed greater spiritual well-being (36.5 vs 33.2, p=0.001). After receiving systemic treatment, psychological distress decreased in cases of advanced cancer and increased in resected cancer, albeit still higher in subjects with advanced cancer, particularly anxiety (61.4 vs 60.9) and depression (61.0 vs 60.6), (p=0.001 in both cases). Conclusion Patients with advanced cancer exhibit greater psychological distress, use more coping strategies, and have less spiritual well-being, but their psychological distress improves with antineoplastic treatment.

  • Long-term survival and performance status of cancer patients after discharge from ICU (intensive care unit).

    by Marta Zafra, Andres Carrillo, Maria Angeles Vicente, Manuel Sánchez Cánovas, Alejandra Ivars Rubio, Inmaculada Ballester Navarro, Alberto Carmona, Francisco Ayala

    E18744 Background: ICU admission is frequently questioned in cancer patients although its survival benefit has been demonstrated. Most studies focus on short-term outcomes, but scarce data are available regarding long-term outcomes and quality of life. Our aim was to evaluate what overall survival (OS) and functional situation can be expected in cancer patients after ICU discharge. Methods: We retrospectively analyzed all consecutive critically ill patients with solid tumors admitted to the medical ICU of a general hospital during 5 years (2011-2015); post-surgery admissions or programmed procedures were excluded. Follow-up data, ECOG performance status (PS), and prognostic factors related either to the tumor, the treatment or the cause of admission, were obtained from medical records. Kaplan-Meier curves and Cox models were used for prognostic evaluation. Results: 138 patients included, of whom 25% died during ICU admission and 93 (68%) were discharged from hospital. Patients: 65%, male; tumor location: 31.9% lung, 16.7% breast, 12.3% colorectal, 10.1% genitourinary; stage IV: 52.1%; current treatment: 58% chemotherapy, 19.6% radiotherapy, 7.2% biological drugs; treatment intention: 44% curative, 12% palliative, 44% non-curative with potential survival benefit. Median OS after discharge from ICU was 17.3 months (95%CI: 11.7-22.9). Mortality during ICU admission was related to acute complications, with only SAPS II score (a measure of comorbidity and acute severity) as a significant factor (OR: 0.95; p = 0.03), while most of post-discharge mortality was related to tumor progression (52.4%). The only prognostic factor for post-discharge OS in the multivariate analysis was disease status at time of discharge (HR: 1.92; p = 0.047). Among discharged patients, PS at baseline was: ECOG 0-1, 60%; ECOG 2: 31%; ECOG 3-4: 9%. After 12 months, 79% of alive patients kept an ECOG 0-2 (0-1: 52%; 2: 27%). Conclusions: A substantial group of cancer patients obtain a significant survival and maintain an ECOG 0-2 after ICU discharge. Concerns about long-term functional outcomes and survival should not preclude admission of cancer patients to ICUs, but further research on post-ICU quality of life is warranted.